
|Articles|October 1, 2004
Minocycline shows promise as safe neuroprotective agent
Tel Hashomer, Israel-Results of preclinical studies suggest that minocycline has potential utility as a neuroprotective agent in the management of optic nerve diseases, said Hani Levkovitch-Verbin, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Beyond the surface: Tackling complex dry eye cases
2
Redefining glaucoma care: Where innovation meets clinical insight
3
Seborrheic dermatitis linked to multiple epithelial barrier diseases
4
SpyGlass Pharma releases positive data from 2 trials of Bimatoprost Drug Pad-IOL System
5


















































.png)


